Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
THIS SHOULD Help $MJTK Boost in Revenue
COURT RULES THAT INSURANCE COMPANY MUST PAY FOR MEDICAL CANNABIS TREATMENT
http://www.naturalblaze.com/2017/03/court-rules-that-insurance-company-must-cover-medical-cannabis-treatment.html?utm_source=Natural+Blaze+Subscribers&utm_medium=email&utm_campaign=cd108c9f0b-RSS_EMAIL_CAMPAIGN&utm_term=0_b73c66b129-cd108c9f0b-387906541
A judge in New Jersey ruled that a man’s insurance company must pay for the cost of his medical cannabis treatment. This may establish an important precedent in the medical industry.
Andrew Watson, who lives in Egg Harbor, New Jersey, enrolled in the state’s medical cannabis program in 2014. He sought financial reimbursement for the purchase of medicinal cannabis over a term of three months.
Watson suffered from chronic neuropathic pain in his left hand. His condition was consistent with New Jersey’s list of qualifying conditions for medical marijuana. He was injured on the job. His initial worker’s compensation claim was denied.
During the hearing, a psychiatrist/neurologist testified on Watson’s behalf. The expert stated that medical marijuana would allow Watson to reduce his prescription opiate use. This would lower risk of addiction and dangerous side effects. The court established that Watson’s cannabis usage is indeed medicinal and that his insurance company should cover his claim.
The presiding judge, Ingrid L. French, stated:
The evidence presented in these proceedings show that the petitioner’s ‘trial’ use of medicinal marijuana has been successful. While the court is sensitive to the controversy surrounding the medicinal use of marijuana, whether or not it should be prescribed for a patient in a state where it is legal to prescribe it is a medical decision that is within the boundaries of the laws in the state.
Opioids Versus Medical Cannabis
Opioids, such as methadone, oxycodone (such as OxyContin®) and hydrocodone (such as Vicodin®), have been responsible for over 183,000 deaths during the last 15 years. Their misuse, abuse and addiction are rampant in the United States. In 2014, almost 2 million Americans abused or were dependent on prescription opioids. On any given day, 1000 people on average are treated in emergency situations for the misuse of these drugs.
As of early 2017, medical cannabis is legal in 28 states. More doctors and patients are likely to choose cannabis over mainstream prescription drugs to treat ailments such as pain. Pain management is a perfect contender for cannabis treatment, considering existing pharmaceutical solutions are quite addictive and outright dangerous.
Judge French called Watson’s choice to use medical cannabis as “cautious, mature, and… exceptionally conscientious.” Many believe that medical cannabis can benefit both patients and insurance companies because treatment is less costly than pharmaceutical options
.
Well a new CEO Scott Wroblreski $NSEH
Scott Wroblreski. Mr. Wroblreski, has over 25 years of experience in the aerospace/aeronautical fields, oil and gas industry working direct or as a consultant for many of leading companies such as Boeing, Lockheed Martin, Northrop Grumman, Orbital Sciences and Safran (formely Snecma). He has held Secret and Top Secret Clearances with an Extensive Background Investigation (EBI, SSBI) by the United States Federal Bureau of Investigation (FBI). He was deputy Director of Launch Nuclear Safety at Lockheed Martin Astronautics for the NASA New Horizons satellite that recently flew by Pluto onto the Kuiper Belts. In addition, Mr. Wroblreski has worked on many prestigious and exciting projects such as the recent Pluto Mission, the Defense Department’s High Speed Superconductivity Project, Boeing 727, 737 & Fokker Passenger to Freighter Conversions, the Conestoga Launch Vehicle, Ariane 4 & 5 Launch Vehicle (European Rocket System), the Atlas 5 Launch Vehicle, the Taurus Launch Vehicle and the Hubble Space Telescope Repair Mission. He has also worked on many commercial aircraft and military projects such as the Airbus A380, the Boeing 777, Boeing’s B-1 Bomber, Boeing’s Chinook Helicopter, and multiple classified and unclassified satellites. Mr. Wroblreski graduated from the Pennsylvania State University with a Bachelor of Science Degree in Aerospace Engineering in 1986 and attended graduate studies in the Engineering Science and Mechanics Department.
Have etrade mobile. $MKAU volume up and down. Pps jumps to .02 then .013 then to 0. Then volume drops to 2.1 mil. Then to 4.5 mil. Then to 0 ???
$NSEH GPSTraxx also gives Data Reading
http://www.theheadlinegroup.com/info_gps2.aspx
">" />
$NSEH also list Pricing on the Product
www.gpstrax.com/pricing.aspx
Added 200k shares in the .02's. $MKAU will move up. Have a great weekend. I will enjoy ClikiaTv
$MKAU should easily Capture $35 million the First Year. Which would Make .35 PPS easily for $MKAU. Take 30% profit .11 Per share . Figure 10-15 times earnings. Should have $MKAU trading at $1.00 -$1.50 pps. My thoughts.
Nice android app. Downloaded on my samsung. Opens to more videos. Free on Google play till March 1st. $MKAU
Another Big Day Ahead For $BIEL
NOW FDA Approved. Actipatch in COSTCO (United States)
Why is $NSEH Dropping